Adaptive Biotechnologies Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-224.6M | — |
| FY2018 | — | $-258.1M | $55.0M |
| FY2019 | — | $571.0M | $96.6M |
| FY2020 | — | $743.3M | $123.4M |
| FY2021 | — | $604.0M | $139.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-224.6M | — |
| FY2018 | — | $-258.1M | $55.0M |
| FY2019 | — | $571.0M | $96.6M |
| FY2020 | — | $743.3M | $123.4M |
| FY2021 | — | $604.0M | $139.1M |